From depressive symptoms to depression in people with epilepsy: Contribution of physical exercise to improve this picture

Epilepsy Research

Volumn 99, Issue 1-2, 2012, Pages 1-13

  Arida, Ricardo M ^a   Cavalheiro, Esper A ^a   Scorza, Fulvio A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Depression; Epilepsy; Exercise; Physical activity; Psychiatric comorbidities; Seizure

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CABERGOLINE; CARBAMAZEPINE; DOPAMINE; ENDORPHIN; GLUTAMIC ACID; MILNACIPRAN; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR; VALPROIC ACID;

ANTICONVULSANT ACTIVITY; BONE DENSITY; BRAIN BLOOD FLOW; DEPRESSION; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXERCISE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MENTAL HEALTH; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; RECEPTOR BINDING; REVIEW; SIDE EFFECT; TREATMENT OUTCOME; VITAMIN D METABOLISM; WEIGHT GAIN;

CLINICAL TRIALS AS TOPIC; DEPRESSION; EPILEPSY; EXERCISE; HUMANS;

EID: 84857924415     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.10.012     Document Type: Review

References (164)

1. Albrecht H. Endorphins, sport, and epilepsy: getting fit or having one. N. Z. Med. J. 1986, 99:915.
2. Allen M.E., Coen D. Naloxone blocking of running-induced mood changes. Ann. Sports Med. 1987, 3:190-195.
3. Altar C.A. Neurotrophins and depression. Trends Pharmacol. Sci. 1999, 20:59-61.
4. Anisman H., Irwin J., Sklar L.S. Deficits of escape performance following catecholamine depletion: implications for behavioral deficits induced by uncontrollable stress. Psychopharmacology (Berl.) 1979, 64:163-170.
5. Anisman H., Remington G., Sklar L.S. Effect of inescapable shock on subsequent escape performance: catecholamine and cholinergic mediation of response initiation and maintenance. Psychopharmacology (Berl.) 1979, 61:107-124.
6. Arida R.M., Vieira A.J., Cavalheiro E.A. Effect of physical exercise on kindling development. Epilepsy Res. 1998, 30:127-132.
7. Arida R.M., Scorza F.A., Santos N.F., Peres C.A., Cavalheiro E.A. Effect of physical exercise on seizure occurrence in a model of temporal lobe epilepsy in rats. Epilepsy Res. 1999, 37:45-52.
8. Arida R.M., Fernandes M.J.S., Scorza F.A., Preti S.C., Cavalheiro E.A. Physical training does not influence interictal LCMRglu in pilocarpine-treated rats with epilepsy. Physiol. Behav. 2003, 79:789-794.
9. Arida R.M., Sanabria E.R.G., Silva A.C., Faria L.C., Scorza F.A., Cavalheiro E.A. Physical training reverts hippocampal electrophysiological changes in rats submitted to the pilocarpine model of epilepsy. Physiol. Behav. 2004, 83:165-171.
10. Arida R.M., Scorza C.A., Scorza F.A., Silva S.G., Naffah-Mazzacoratti M.G., Cavalheiro E.A. Effects of different types of physical exercise on the staining of parvalbumin-positive neurons in the hippocampal formation of rats with epilepsy. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:814-822.
11. Arida R.M., Cavalheiro E.A., da Silva A.C., Scorza F.A. Physical activity and epilepsy: proven and predicted benefits. Sports Med. 2008, 38:607-615.
12. Arida R.M., Scorza F.A., Terra V.C., Cysneiros R.M., Cavalheiro E.A. Physical exercise in rats with epilepsy is protective against seizures: evidence of animal studies. Arq. Neuropsiquiatr. 2009, 67:1013-1016.
13. Arida R.M., Scorza F.A., Scorza C.A., Cavalheiro E.A. Is physical activity beneficial for recovery in temporal lobe epilepsy? Evidences from animal studies. Neurosci. Biobehav. Rev. 2009, 33:422-431.
14. Arida R.M., Scorza F.A., Terra V.C., Scorza C.A., de Almeida A.C., Cavalheiro E.A. Physical exercise in epilepsy: what kind of stressor is it?. Epilepsy Behav. 2009, 16:381-387.
15. Auvergne R., Leré C., El Bahh B., Arthaud S., Lespinet V., Rougier A., et al. Delayed kindling epileptogenesis and increased neurogenesis in adult rats housed in an enriched environment. Brain Res. 2002, 954:277-285.
16. Aydemir O., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:261-265.
17. Babyak M., Blumenthal J.A., Herman S., Khatri P., Doraiswamy M., Moore K., et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom. Med. 2000, 62:633-638.
18. Barchas J., Freedman D. Brain Monoamines: response to physiological stress. Biochem. Pharmacol. 1963, 12:1232-1235.
19. Biggs C.S., Pearce B.R., Fowler L.J., Whitton P.S. Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain an in vivo microdialysis study. J. Neurochem. 1992, 59:1702-1708.
20. Bjørnebekk A., Mathé A.A., Brené S. The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int. J. Neuropsychopharmacol. 2005, 8(3):357-368.
21. Bjørnebekk A., Mathé A.A., Brené S. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 2010, 20(7):820-828.
22. Bhagwagar Z., Wylezinska M., Jezzard P., Evans J., Ashworth F., Sule A., et al. Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol. Psychiatry 2007, 61:806-812.
23. Bland S., Gonzale R., Schallert T. Movement related glutamate levels in rat hippocampus, striatum, and sensorimotor cortex. Neurosci. Lett. 1999, 277:119-122.
24. Blomstrand E., Perrett D., Parry-Billings M., Newsholme E.A. Effect of sustained exercise on plasma amino acid concentrations and on 5-hydroxytryptamine metabolism in six different brain regions in the rat. Acta Physiol. Scand. 1989, 136:473-481.
25. Bloomer R.J., Goldfarb A.H. Anaerobic exercise and oxidative stress: a review. Can. J. Appl. Physiol. 2004, 29:245-263.
26. Boecker H., Sprenger T., Spilker M.E., Henriksen G., Koppenhoefer M., Wagner K.J., et al. The runner's high: opioidergic mechanisms in the human brain. Cereb. Cortex 2008, 18:2523-2531.
27. Bortolotto Z.A., Cavalheiro E.A. Effect of DSP4 on hippocampal kindling in rats. Pharmacol. Biochem. Behav. 1986, 24:777-779.
28. Brosse A.L., Sheets E.S., Lett H.S., Blumenthal J.A. Exercise and the treatment of clinical depression in adults: recent findings and future directions. Sports Med. 2002, 32:741-760.
29. Brown B.S., Payne T., Kim C., Moore G., Krebs P., Martin W. Chronic response of rat brain norepinephrine and serotonin levels to endurance training. J. Appl. Physiol. 1979, 46:19-23.
30. Browning R.A., Hoffmann W.E., Simonton R.L. Changes in seizure susceptibility after intracerebral treatment with 5,7-dihydroxytryptamine: role of serotonergic neurons. Ann. N. Y. Acad. Sci. 1978, 305:437-456.
31. Browning R.A., Wade D.R., Marcinczyk M., Long G.L., Jobe P.C. Regional brain abnormalities in norepinephrine uptake and dopamine beta-hydroxylase activity in the genetically epilepsy prone rat. J. Pharmacol. Exp. Ther. 1989, 249:229-235.
32. Burke K., Chandler C.J., Starr B.S., Starr M.S. Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol. Biochem. Behav. 1990, 36:729-733.
33. Camilo F., Scorza F.A., de Albuquerque M., Vancini R.L., Cavalheiro E.A., Arida R.M. Evaluation of intense physical effort in subjects with temporal lobe epilepsy. Arq. Neuropsiquiatr. 2009, 67:1007-1012.
34. Chaouloff F., Laude D., Guezennec Y., Elghozi J.L. Motor activity increases tryptophan, 5-hydroxyindoleacetic acid, and homovanillic acid in ventricular cerebrospinal fluid of the conscious rat. J. Neurochem. 1986, 46:1313-1316.
35. Chaouloff F., Laude D., Merino D., Serrurrier B., Guezennec Y., Elghozi J.L. Amphetamine and alpha-methyl-p-tyrosine affect the exercise-induced imbalance between the availability of tryptophan and synthesis of serotonin in the brain of the rat. Neuropharmacology 1987, 26:1099-1106.
36. Chaouloff F. Physical exercise and brain monoamines: a review. Acta Physiol. Scand. 1989, 137:1-13.
37. Conant K.D., Morgan A.K., Muzykewicz D., Clark D.C., Thiele E.A. A karate program for improving self-concept and quality of life in childhood epilepsy: results of a pilot study. Epilepsy Behav. 2008, 12:61-65.
38. Croarkin P.E., Levinson A.J., Daskalakis Z.J. Evidence for GABAergic inhibitory deficits in major depressive disorder. Neurosci. Biobehav. Rev. 2011, 35:818-825.
39. Dailey J.W., Naritoku D.K. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem. Pharmacol. 1996, 52:1323-1329.
40. Dailly E., Chenu F., Renard C.E., Bourin M. Dopamine, depression and antidepressants. Fundam. Clin. Pharmacol. 2004, 18:601-607.
41. Davis J.M., Bailey S.P. Possible mechanisms of central nervous system fatigue during exercise. Med. Sci. Sports Exerc. 1997, 29:45-57.
42. De Oliveira M.S., da Silva Fernandes M.J., Scorza F.A., Persike D.S., Scorza C.A., da Ponte J.B., et al. Acute and chronic exercise modulates the expression of MOR opioid receptors in the hippocampal formation of rats. Brain Res. Bull. 2010, 83:278-283.
43. De Vry J. 5-HT1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berl.) 1995, 121:1-26.
44. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., et al. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry 1999, 46:1375-1387.
45. Dubow J.S., Kelly J.P. Epilepsy in sports and recreation. Sports Med. 2003, 33:499-516.
46. Duman R.S. Role of neurotrophic factors in the etiology and treatment of mood disorders. Neuromol. Med. 2004, 5:11-25.
47. Duncan J.S., Sander J.W., Sisodiya S.M., Walker M.C. Adult epilepsy. Lancet 2006, 367(9516):1087-1100.
48. Dunlop B.W., Nemeroff C.B. The role of dopamine in the pathophysiology of depression. Arch. Gen. Psychiatry 2007, 64:327-337.
49. Dunn A.L., Reigle T.G., Youngstedt S.D., Armstrong R.B., Dishman R.K. Brain norepinephrine and metabolites after treadmill training and wheel running in rats. Med. Sci. Sports Exerc. 1996, 28:204-209.
50. Dunn A.L., Trivedi M.H., O'Neal H.A. Physical activity dose-response effects on outcomes of depression and anxiety. Med. Sci. Sports Exerc. 2001, 33:S587-S597.
51. Dunn A.L., Trivedi M.H., Kampert J.B., Clark C.G., Chambliss H.O. Exercise treatment for depression: efficacy and dose response. Am. J. Prev. Med. 2005, 28:1-8.
52. Dworak M., Diel P., Voss S., Hollmann W. Strüder Intense exercise increases adenosine concentrations in rat brain: implications for a homeostatic sleep drive. Neuroscience 2007, 150:789-795.
53. Elliott J.O., Jacobson M.P. Bone loss in epilepsy: barriers to prevention, diagnosis, and treatment. Epilepsy Behav. 2006, 8:169-175.
54. Eriksen H.R., Ellertsen B., Gronningsaeter H., Nakken K.O., Loyning Y., Ursin H. Physical exercise in women with intractable epilepsy. Epilepsia 1994, 35:1256-1264.
55. Esquivel E., Chaussain M., Plouin P., Ponsot G., Arthuis M. Physical exercise and voluntary hyperventilation in childhood absence epilepsy. Electroenceph. Clin. Neurophysiol. 1991, 79:127-132.
56. Farmer J., Zhao X., van P.H., Wodtke K., Gage F.H., Christie B.R. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004, 124:71-79.
57. Fassio A., Rossi F., Bonanno G., Raiteri M. GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels. J. Neurosci. Res. 1999, 57:324-331.
58. Ferris L.T., Williams J.S., Shen C.L. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med. Sci. Sports Exerc. 2007, 39:728-734.
59. Fisher R.S., van Emde Boas W., Blume W., Elger C., Genton P., Lee P., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46:470-472.
60. Fountain N.B., May A.C. Epilepsy and athletics. Clin. Sports Med. 2003, 22:605-616.
61. Frankowska M., Filip M., Przegaliński E. Effects of GABAB receptor ligands in animal tests of depression and anxiety. Pharmacol. Rep. 2007, 59:645-655.
62. Fujimaki K., Morinobu S., Duman R.S. Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 2000, 22:42-51.
63. Gaitatzis A., Trimble M.R., Sander J.W. The psychiatric comorbidity of epilepsy. Acta Neurol. Scand. 2004, 110:207-220.
64. Gambarana C., Ghiglieri O., Taddei I., Tagliamonte A., De Montis M.G. Imipramine and fluoxetine prevent the stress-induced escape deficits in rats through a distinct mechanism of action. Behav. Pharmacol. 1995, 6:66-73.
65. Garlow S.J., Musselman D.L., Nemeroff C.B. The neurochemistry of the mood disorders. Neurobiology of Mental Illness 1999, 348-365. Oxford University Press, New York. D.S. Charney, E.J. Nesler, B.S. Bunney (Eds.).
66. Gobbo O.L., O'Mara S.M. Exercise, but not environmental enrichment, improves learning after kainic acid-induced hippocampal neurodegeneration in association with an increase in brain-derived neurotrophic factor. Behav. Brain Res. 2005, 159:21-26.
67. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255:267-268.
68. Gordon R., Spector S., Sjoerdsma A., Udenfriend S. Increased synthesis of norepinephrine and epinephrine in the intact rat during exercise and exposure to cold. J. Pharmacol. Exp. Ther. 1966, 153:440-447.
69. Gotze W., Kubicki S., Munter M., Teichmann J. Effect of physical exercise on seizure threshold. Dis. Nerv. Syst. 1967, 28:664-667.
70. Guadalupe-Grau A., Fuentes T., Guerra B., Calbet J.A. Exercise and bone mass in adults. Sports Med. 2009, 39:439-468.
71. Harber V.J., Sutton J.R. Endorphins and exercise. Sports Med. 1984, 1:154-171.
72. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 2007, 64:193-200.
73. Hattori S., Naoi M., Nishino H. Striatal dopamine turnover during treadmill running in the rat: relation to the speed of running. Brain Res. Bull. 1994, 35:41-49.
74. Heise J., Buckworth J., McAuley J.W., Long L., Kirby T. Exercise Training Results in Positive Outcomes in Persons with Epilepsy. Clinical Exercise Physiol. 2002, 4:79-84.
75. Hernandez E.J., Williams P.A., Dudek F.E. Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy. Epilepsia 2002, 43:1337-1345.
76. Hill L.E., Droste S.K., Nutt D.J., Linthorst A.C., Reul J.M. Voluntary exercise alters GABA(A) receptor subunit and glutamic acid decarboxylase-67 gene expression in the rat forebrain. J. Psychopharmacol. 2010, 24:745-756.
77. Horyd W., Gryziak J., Niedzielska K., Zielinski J.J. Exercise effect on seizure discharges in epileptics. Neurol. Neurochir. Pol. 1981, 6:545-552.
78. Ito S., Suhara T., Ito H., Yasuno F., Ichimiya T., Takano A., et al. Changes in central 5-HT(1A) receptor binding in mesial temporal epilepsy measured by positron emission tomography with [(11)C]WAY100635. Epilepsy Res. 2007, 73:111-118.
79. Janal M.N., Colt E.W.D., Clark W.C., Glusman M. Pain sensitivity, mood, and plasma endocrine levels in man following long distance running: effects of naloxone. Pain 1984, 19:13-25.
80. Jalava M., Sillanpaa M. Physical activity, health related fitness and health experience in adults with childhood-onset epilepsy: a controlled study. Epilepsia 1997, 38:424-429.
81. Jobe P.C., Dailey J.W., Wernicke J.F. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit. Rev. Neurobiol. 1999, 13:317-356.
82. Knaepen K., Goekint M., Heyman E.M., Meeusen R. Neuroplasticity-exercise-induced response of peripheral brain-derived neurotrophic factor: a systematic review of experimental studies in human subjects. Sports Med. 2010, 40:765-801.
83. Karege F., Perret G., Bondolfi M.S., Bertschy G., Aubry J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109:143-148.
84. Kaufman K.R. Antiepileptic drugs in the treatment of psychiatric disorders. Epilepsy Behav. 2011, 21:1-11.
85. Kobau R., Gilliam F., Thurman D.J. Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Health Styles Survey. Epilepsia 2006, 47:1915-1921.
86. Kramer J.M., Plowey E.D., Beatty J.A., Little H.R., Waldrop T.G. Hypothalamus, hypertension, and exercise. Brain Res. Bull. 2000, 53:77-85.
87. Kuijer A. Epilepsy and exercise electroencephalographical and biochemical studies. Advances in Epileptology: The 10th epilepsy International Symposium 1980, 543. Raven Press, New York. J.A. Wada, J.K. Penry (Eds.).
88. LaFrance W.C., Kanner A.M., Hermann B. Psychiatric comorbidities in epilepsy. Int. Rev. Neurobiol. 2008, 83:347-383.
89. Landvogt C., Buchholz H.G., Bernedo V., Schreckenberger M., Werhahn K.J. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy. Epilepsia 2010, 51:1699-1706.
90. Little H.R., Kramer J.M., Beatty J.A., Waldrop T.G. Chronic exercise increases GAD gene expression in the caudal hypothalamus of spontaneously hypertensive rats. Brain Res. Mol. Brain Res. 2001, 95:48-54.
91. Löscher W., Pagliusi S.R., Muller F. l-5-Hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain. Neuropharmacology 1984, 23:1041-1048.
92. Löscher W., Czuczwar S.J. Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. Eur. J. Pharmacol. 1986, 128:55-65.
93. Luger A., Deuster P.A., Kyle S.B., Gallucci W.T., Montgomery L.C., Gold P.W., et al. Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. N. Engl. J. Med. 1987, 316:1309-1315.
94. Lundgren T., Dahlr J., Yardi N., Melin L. Acceptance and Commitment Therapy and yoga for drug-refractory epilepsy: a randomized controlled trial. Epilepsy Behav. 2008, 13:102-108.
95. Maes M., Meltzer H.Y. The serotonin hypothesis of major depression. Psychopharmacology: The Fourth Generation of Progress 1995, 933-944. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
96. Markoff R.A., Ryan P., Young T. Endorphin and mood changes in long-distance running. Med. Sci. Sports Exerc. 1982, 14:11-15.
97. Mata J., Thompson R.J., Gotlib I.H. BDNF genotype moderates the relation between physical activity and depressive symptoms. Health Psychol. 2010, 29:130-133.
98. Matthes S., Mosienko V., Bashammakh S., Alenina N., Bader M. Tryptophan hydroxylase as novel target for the treatment of depressive disorders. Pharmacology 2010, 85:95-109.
99. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004, 27:589-594.
100. McAuley J.W., Long L., Heise J., Kirby T., Buckworth J., Pitt C., et al. A prospective evaluation of the effects of a 12-week outpatient exercise program on clinical and behavioral outcomes in patients with epilepsy. Epilepsy Behav. 2001, 2:592-600.
101. McIntyre D.C. Catecholamines involvement in amygdala kindling of the rat. Kindling 1981, 67-80. Raven Press, New York. J.A. Wada (Ed.).
102. McIntyre D.C., Edson N. Effect of norepinephrine depletion on dorsal hippocampus kindling in rats. Exp. Neurol. 1982, 77:700-704.
103. McIntyre D.C., Edson N., Chao G., Knowles V. Differential effect of acute vs chronic desmethylimipramine on the rate of amygdale kindling in rats. Exp. Neurol. 1982, 78:158-166.
104. Meeusen R., De Meirleir K. Exercise and brain neurotransmission. Sports Med. 1995, 20:160-188.
105. Meeusen R., Thorré K., Chaouloff F., Sarre S., De Meirleir K., Ebinger G., Michotte Y. Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats. Brain Res. 1996, 740:245-252.
106. Mendes de Freitas R., Aguiar L.M., Vasconcelos S.M., Sousa F.C., Viana G.S., Fonteles M.M. Modifications in muscarinic, dopaminergic and serotonergic receptors concentrations in the hippocampus and striatum of epileptic rats. Life Sci. 2005, 78:253-258.
107. Miller H.L., Delgado P.L., Salomon R.M., Heningar G.R., Charney D.S. Effects of alpha-methyl-paratyrosine (AMPT) in drug free depressed patients. Neuropsychopharmacology 1996, 14:151-157.
108. Murakami T., Okada M., Kawata Y., Zhu G., Kamata A., Kaneko S. Determination of effects of antiepileptic drugs on SNAREs mediated hippocampal monoamine release using in vivo microdialysis. Br. J. Pharmacol. 2001, 134:507-520.
109. Nakken K.O., Bjorholt P.G., Johannessen S.I., Loyning T., Lind E. Effect of physical training on aerobic capacity, seizure occurrence, and serum level of antiepileptic drugs in adults with epilepsy. Epilepsia 1990, 31:88-94.
110. Nakken K.O., Løyning A., Løyning T., Gløersen G., Larsson P.G. Does physical exercise influence the occurrence of epileptiform EEG discharges in children?. Epilepsia 1997, 38:279-284.
111. Neeper S., Gomez-Pinilla F., Choi J., Cotman C.W. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 1996, 726:49-56.
112. Nemeroff C.B., Vale W.W. The neurobiology of depression: inroads to treatment and new drug discovery. J. Clin. Psychiatry 2005, 66:5-13.
113. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
114. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
115. Nitz D.A., McNaughton B.L. Hippocampal EEG and unit activity responses to modulation of serotonergic median raphe neurons in the freely behaving rat. Learn. Mem. 1999, 6:153-167.
116. Noe K.H., Locke D.E., Sirven J.I. Treatment of depression in patients with epilepsy. Curr. Treat Options Neurol. 2011, 13:371-379.
117. Ogoh S., Ainslie P.N. Cerebral blood flow during exercise: mechanisms of regulation. J. Appl. Physiol. 2009, 107:1370-1380.
118. Ostman I., Nyback H. Adaptive changes in central and peripheral noradrenergic neurons in rats, following chronic exercise. Neuroscience 1976, 1:41-47.
119. Ottman R., Lipton R.B., Ettinger A.B., Cramer J.A., Reed M.L., Morrison A., et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011, 52:308-315.
120. Pacia S.V., Doyle W.K., Broderick P.A. Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry. Brain Res. 2001, 899:106-111.
121. Pariante C.M., Lightman S.L. The HPA axis in major depression: classical theories and new developments. Trends Neurosci. 2008, 31:464-468.
122. Perucca E., Tomson T. The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011, 10:446-456.
123. Potts J.T., Paton J.F., Mitchell J.H., Garry M.G., Kline G., Anguelov P.T., et al. Contraction-sensitive skeletal muscle afferents inhibit arterial baroreceptor signalling in the nucleus of the solitary tract: role of intrinsic GABA interneurons. Neuroscience 2003, 119:201-214.
124. Poulton N.P., Muir G.D. Treadmill training ameliorates dopamine loss but not behavioral deficits in hemi-Parkinsonian rats. Exp. Neurol. 2005, 193:181-197.
125. Power B.M., Hackett L.P., Dusci L.J., Ilett K.F. Antidepressant toxicity and the need for identification and concentration monitoring in overdose. Clin. Pharmacokinet. 1995, 29:154-171.
126. Rambo L.M., Ribeiro L.R., Oliveira M.S., Furian A.F., Lima F.D., Souza M.A., et al. Additive anticonvulsant effects of creatine supplementation and physical exercise against pentylenetetrazol-induced seizures. Neurochem. Int. 2009, 55:333-340.
127. Rasmussen P., Brassard P., Adser H., Pedersen M.V., Leick L., Hart E., et al. Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp. Physiol. 2009, 94:1062-1069.
128. Reiss J.I., Dishman R.K., Boyd H.E., Robinson J.K., Holmes P.V. Chronic activity wheel running reduces the severity of kainic acid-induced seizures in the rat: possible role of galanin. Brain Res. 2009, 1266:54-63.
129. Richelson E. Biological basis of depression and therapeutic relevance. J. Clin. Psychiatry 1991, 52:4-10.
130. Roth D., Goode K., Williams V., Faught E. Physical exercise, stressful life experience, and depression in adults with epilepsy. Epilepsia 1994, 35:1248-1255.
131. Russo-Neustadt A., Beard R.C., Cotman C.W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 1999, 21:679-682.
132. Russo-Neustadt A., Alejandre H., Garcia C., Ivy A.S., Chen M.J. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology 2004, 29:2189-2199.
133. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1999, 56:1043-1047.
134. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., et al. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 2000, 57:174-180.
135. Sathyaprabha T.N., Satishchandra P., Pradhan C., Sinha S., Kaveri B., Thennarasu K., et al. Modulation of cardiac autonomic balance with adjuvant yoga therapy in patients with refractory epilepsy. Epilepsy Behav. 2008, 12:245-252.
136. Sartori C.R., Pelágio F.C., Teixeira S.A., Valentinuzzi V.S., Nascimento A.L., Rogério F. Effects of voluntary running on spatial memory and mature brain-derived neurotrophic factor expression in mice hippocampus after status epilepticus. Behav. Brain Res. 2009, 203(5):165-172.
137. Savic I., Lindström P., Gulyás B., Halldin C., Andrée B., Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology 2004, 62:1343-1351.
138. Schildkraut J.J. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting response to treatment: preliminary findings. Am. J. Psychiatry 1973, 130:695-699.
139. Seifert T., Brassard P., Wissenberg M., Rasmussen P., Nordby P., Stallknecht B. Endurance training enhances BDNF release from the human brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 298:R372-R377.
140. Setkowicz Z., Mazur A. Physical training decreases susceptibility to subsequent pilocarpine-induced seizures in the rat. Epilepsy Res. 2006, 71:142-148.
141. Shiah I.S., Yatham L.N. GABA function in mood disorders: an update and critical review. Life Sci. 1998, 63:1289-1303.
142. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 2003, 54:70-75.
143. Shirayama Y., Chen A.C.H., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
144. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 1997, 56:131-137.
145. +-ATPase activity, seizures, and oxidative stress. Epilepsia 2008, 50:811-823.
146. Starr M.S. The role of dopamine in epilepsy. Synapse 1996, 22:159-194.
147. Streeter C.C., Jensen J.E., Perlmutter R.M., Cabral H.J., Tian H., Terhune D.B., et al. Yoga Asana sessions increase brain GABA levels: a pilot study. J. Altern. Complement. Med. 2007, 13:419-426.
148. Streeter C.C., Whitfield T.H., Owen L., Rein T., Karri S.K., Yakhkind A., et al. Effects of yoga versus walking on mood anxiety, and brain GABA levels: a randomized controlled MRS study. J. Altern. Complement. Med. 2010, 16:1145-1152.
149. Takahashi H., Yoshida K., Higuchi H., Shimizu T., Inoue T., Koyama T. Addition of a dopamine agonist, cabergoline, to a serotonin-noradrenalin reuptake inhibitor, milnacipran as a therapeutic option in the treatment of refractory depression: two case reports. Clin. Neuropharmacol. 2003, 26:230-232.
150. Tang S.W., Chu E., Hui T., Helmeste D., Law C. Influence of exercise on serum brain-derived neurotrophic factor concentrations in healthy human subjects. Neurosci. Lett. 2008, 431:62-65.
151. Tellez-Zenteno J.F., Patten S.B., Jette N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
152. Terasawa E., Kurian J.R., Guerriero K.A., Kenealy B.P., Hutz E.D., Keen K. Recent discoveries on the control of GnRH neurons in nonhuman primates. J. Neuroendocrinol. 2010, 22:630-638.
153. Thapar A., Kerr M., Harold G. Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. Epilepsy Behav. 2009, 14:134-140.
154. Toczek M.T., Carson R.E., Lang L., Ma Y., Spanaki M.V., Der M.G., et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 2003, 60:749-756.
155. Thoren P., Floras J.S., Hoffman P., Seals D.R. Endorphins and exercise: physiological mechanisms and clinical implications. Med. Sci. Sports Exerc. 1990, 22:417-428.
156. Tutkun E., Ayyildiz M., Agar E. Short-duration swimming exercise decreases penicillin-induced epileptiform ECoG activity in rats. Acta Neurobiol. Exp. 2010, 70:382-389.
157. Trindade-Filho E.M., de Castro-Neto E.F., de A., Carvalho R., Lima E., Scorza F.A., Amado D., et al. Serotonin depletion effects on the pilocarpine model of epilepsy. Epilepsy Res. 2008, 82:194-199.
158. Vancini R.L., de Lira C.A., Scorza F.A., de Albuquerque M., Sousa B.S., de Lima C., et al. Cardiorespiratory and electroencephalographic responses to exhaustive acute physical exercise in people with temporal lobe epilepsy. Epilepsy Behav. 2010, 19:504-508.
159. Vaynman S., Gomez-Pinilla F. License to run: exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophin. Neurorehabil. Neural Repair 2005, 19:283-294.
160. Veenstra-VanderWeele J., Anderson G.M., Cook E.H. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur. J. Pharmacol. 2000, 410:165-181.
161. Yuen A.W., Thompson P.J., Flugel D., Bell G.S., Sander J.W. Mortality and morbidity rates are increased in people with epilepsy: is stress part of the equation?. Epilepsy Behav. 2007, 10:1-7.
162. Wasserman K., Wipp B., Koyal S., et al. Anaerobic threshold and respiratory gas exchange during exercise. J. Appl. Physiol. 1973, 35:236-243.
163. Werhahn K.J., Landvogt C., Klimpe S., Buchholz H.G., Yakushev I., Siessmeier T., et al. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study. Epilepsia 2006, 47:1392-1396.
164. Willner P. The mesolimbic dopamine system as a target for rapid antidepressant action. Int. Clin. Psychopharmacol. 1997, (Suppl. 3):S7-S14.